| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |